You are here

Article info

Article menu
Download PDFPDF
Original article
Hyaluronan synthase 2 is an adverse prognostic marker in androgen receptor-negative breast cancer

Authors

  1. Correspondence to Dr Gary M Tse, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Ngan Shing Street, Shatin, NT, Hong Kong; garytse{at}cuhk.edu.hk
View Full Text

Citation

Zhang H, Tsang JYS, Ni Y, et al
Hyaluronan synthase 2 is an adverse prognostic marker in androgen receptor-negative breast cancer
Journal of Clinical Pathology 2016;69:1055-1062.

Publication history

  • Received January 8, 2016
  • Revised April 6, 2016
  • Accepted April 24, 2016
  • First published May 11, 2016.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/